Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Sovereign AI Partners With Accenture (NYSE:ACN) and Palantir (NASDAQ:PLTR) for AI Data Center Expansion

Sovereign AI (S-AI), a UK-based provider of AI infrastructure and solutions, has chosen Accenture (NYSE:ACN) and Palantir Technologies Inc. (NASDAQ:PLTR) to assist in building and scaling next-generation AI data centers across Europe, the Middle East, and Africa. The initiative is intended to establish a …

Team Kalkine | 21 January 2026

Rapt Therapeutics (NASDAQ:RAPT) Surges 64% on USD 2Bn GSK Acquisition Deal

Shares of Rapt Therapeutics (NASDAQ:RAPT) climbed 64% on Tuesday to close at USD 57.57, following the announcement that the immunology-focused biotechnology company had agreed to be acquired by British pharmaceutical group GSK (NYSE: GSK). Under the terms of the agreement, GSK will acquire Rapt …

Team Kalkine | 21 January 2026

Oklo (NYSE:OKLO) Shares Slide 5% Amid Tariff Concerns

Shares of Oklo Inc. (NYSE:OKLO) moved lower on Tuesday, closing the session down 5.3% at USD 89.93, as U.S. equity markets recorded their weakest performance in several months. The decline came as both the S&P 500 and the Nasdaq Composite fell sharply, dropping 2.1% …

Team Kalkine | 21 January 2026

Iamgold (NYSE: IAG) Leaps over 15% on Q4 Production Update and 2026 Outlook

Shares of Iamgold (NYSE:IAG) advanced over 15% on Tuesday to close at USD 19.83 after the gold producer released preliminary operating results for the fourth quarter and outlined expectations for the coming year. The stock move followed details pointing to higher production levels and …

Team Kalkine | 21 January 2026

What Triggered Target Price Cuts for MiMedx (NASDAQ:MDXG) and Crown Castle (NYSE: CCI)?

Recent target price reductions for MiMedx Group and Crown Castle were driven by analyst reassessments following quarterly earnings releases and forward-looking assumptions. Although both companies reported earnings per share above consensus expectations, research firms adjusted valuation models to reflect updated revenue trends, margin considerations, …

Team Kalkine | 21 January 2026

Global Markets Slide as U.S.–EU Trade Tensions and Rising Yields Weigh on Risk Sentiment

Market Movers:On Friday, the top gainers were Venus Concept Inc. (+459.44%), followed by TNL Mediagene (+65.68%). On the contrary, Springview Holdings Ltd. (-57.32%), and Rich Sparkle Holdings Limited (-36.88%) declined the most the same day.

Team Kalkine | 20 January 2026

Trump Escalates Transatlantic Tensions with Tariff Threats and Diplomatic Pressure Ahead of Davos

The latest flashpoint came after French President Emmanuel Macron declined to join a Trump-backed peace initiative, prompting the US president to threaten a 200% tariff on French wine and other related products.

Team Kalkine | 20 January 2026

Silver at the Edge of History: Watch These Three NYSE-Listed Silver Stocks for Today

Markets tend to move before the narrative catches up. Recent pre-market strength in silver stocks,(NYSE: EXK), (NYSE:SVM) and (NYSE: FSM) illustrates this pattern, with prices advancing decisively even before the opening bell

Team Kalkine | 20 January 2026

AlphaTON Capital (NASDAQ:ATON) to Launch Privacy-Preserving AI Agents on Telegram

AlphaTON Capital Corp (NASDAQ:ATON) announced a definitive agreement with the Midnight Foundation to integrate privacy-preserving AI agents within Telegram, which has an addressable market of one billion monthly active users. The collaboration combines AlphaTON’s Cocoon AI infrastructure with Midnight’s zero-knowledge blockchain to enable fully …

Team Kalkine | 20 January 2026

ImmunityBio (NASDAQ: IBRX) Shares Surge on ANKTIVA® sBLA FDA Updates

ImmunityBio, Inc. (NASDAQ:IBRX) recently conducted a Type B End-of-Phase meeting with the U.S. FDA regarding its supplemental Biologics License Application (sBLA) for ANKTIVA® (nogapendekin alfa inbakicept) plus Bacillus Calmette-Guérin (BCG). The application focuses on patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) presenting with …

Team Kalkine | 20 January 2026